[ad_1]
On Monday (23) good news was released about the global progress of the vaccine. Although the AstraZeneca vaccine is not as effective as Pfizer and Moderna, it has greater advantages over other vaccines in terms of price and distribution.
As global epidemic prevention measures may loosen due to the peak holiday season, British Prime Minister Boris Johnson announced that the Great Lockdown in England will be lifted on December 2, but this is a conditional release.
Johnson & Johnson said: “For the first time since the epidemic began, we have seen a way out of the pandemic. We know in our hearts that we will be successful next year.”
Johnson & Johnson announced that the UK will re-implement the three-tier restraint system. According to the number of virus infections and different levels of restrictions in different regions, these outbreak prevention classifications will be stricter than before the second lockdown. Details are expected to be announced Thursday.
The Christmas plan is currently being formulated. Johnson & Johnson is consulting with leaders from Wales, Scotland and Northern Ireland. Johnson & Johnson emphasized: “I cannot say that Christmas this year is normal. But in this difficult period, there are several. For people of faith, it is precious to be able to spend time with loved ones.”
The biggest advantage of the AstraZeneca vaccine
Pfizer’s new corona (PFE-US) and Moderna (MRNA-US) vaccines have been reported to be 95% effective. The new corona vaccine jointly developed by AstraZeneca (AZN-US) and the University of Oxford on Monday has an average effectiveness of just 70%. But this does not mean that the AstraZeneca vaccine does not have any market advantage.
After various vaccines came out, the world has also turned its attention to follow-up issues like large-scale vaccine production, vaccine distribution, and cost.
Analysts at investment bank Jefferies said the AstraZeneca vaccine appears to have advantages in terms of storage, affordability and distribution.
AstraZeneca vaccines can be stored, transported and processed under normal refrigeration conditions (36-46 Fahrenheit) for at least 6 months, and can be used in existing healthcare settings. AstraZeneca also promises that it will not be profitable during the new corona pandemic. Distribute vaccines locally.
In terms of price, the price of the AstraZeneca vaccine is approximately US $ 3-4 (approximately Taiwan $ 85 to 114), much lower than the prices of the Hui (US $ 18.34) and Moderna (US $ 25) vaccines. Americans).
Deutsche Bank lists emerging markets such as Brazil, Mexico, India and Indonesia as the potential biggest beneficiaries of AstraZeneca vaccines because AstraZeneca’s production and distribution costs are lower, which is particularly suitable for low- and middle-income countries.
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said that vaccine developers hope to develop a vaccine that is at least 75% effective, but 50% or 60% effectiveness of the vaccine is acceptable. from.
In this statement, Fauci also stated that the 70% effectiveness of the AstraZeneca vaccine is reasonable and acceptable.
The misappropriation, plagiarism and reprinting of the Chinese website “financial sector website” are strictly prohibited.
[ad_2]
